首页> Kidney360> Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON.

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON.

导出 LinkOut

翻译打印收藏纠错

第一作者： Phoom,Narongkiatikhun

第一单位： Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA.;Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

作者： Phoom,Narongkiatikhun ^[1] ; Petter,Bjornstad ^[2]

作者单位： Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA.;Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. ^[1] Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA. ^[2]

DOI 10.34067/KID.0000001278

PMID 42241117

发布时间 2026-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Kidney360

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

检索历史清除

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON.

Kidney360

相似文献

同项目论文

Kidney360

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON.

Kidney360

相似文献

同项目论文

Kidney360

相关期刊

检索历史清除